close search
Home Mutual FundsEquitySectoral FundNippon India Pharma Fund

Nippon India Pharma Fund

The fund details shown here are of the Growth Plan option and belongs to the Equity, Sectoral Fund category.

The NAV for Nippon India Pharma Fund Fund is 526.297 as of 17 Jul 2025. NAV or Net Asset Value, is a crucial metric in the context of mutual funds. It represents the per - unit market value of a mutual fund scheme. NAV is calculated by the fund house on every business day and is a key factor in determining the value of an investor's holdings in the mutual fund.

This fund has given 24.53% annualized return for the last 3 years.

At present Nippon India Pharma Fund has not been rated by us.

  • 1M
  • 3M
  • 6M
  • 1YR
  • 3YR
  • 5YR
  • 10YR
  • Since Inception

Performance

Monthly SIP of   ₹    for

Below table shows comparison of Nippon India Pharma Fund with respect to the investments in Fixed Deposit and Gold for the Total investment of ₹36,000 over the period of 3 years.

Total Value Gain Return %
This Fund

51,611

15,611

24.85%
Bank FD

39,824

3,824

 6.5%
Gold

40,770

4,770

 8.00%

Fund Information

  • As of 28 Feb 2025, fund size of Nippon India Pharma Fund is 6,891.31 Cr.

  • Nippon India Pharma Fund shown here is of Growth plan.

  • The Total Expense Ratio (TER) of the fund is 1.85%. The Total Expense Ratio (TER) is a measure that represents the total costs associated with managing and operating a mutual fund as a percentage of its average Assets under Management (AUM). It provides an insight into the overall expenses they will incur by investing in the fund.

  • Nippon India Pharma Fund is an Equity oriented mutual fund in the - Sectoral Fund category.

  • S&P BSE Healthcare TRI is the benchmark for Nippon India Pharma Fund. A benchmark for a mutual fund serves as a standard for performance comparison, helping investors assess how well the fund is meeting its objectives and how it fares against relevant market indicators. Investors often compare the fund's performance with the benchmark as well as its peers.

  • The inception date of a mutual fund refers to the date when the fund was first established and began operations. It is the starting point from which the fund's performance, returns, and other key metrics are calculated. The fund was started on 01 Jun 2004 as at present it is 21 years old fund.

  • Name of the AMC is Nippon India Mutual Funds. Click here to know more about Nippon India Mutual Funds.

Fund Managed By

Fund managers make investment decisions, optimizing returns and managing risks for portfolios. Responsibilities include market analysis, performance monitoring. Nippon India Pharma Fund managed by following fund manager(s);

How does the Return Comparison of the Nippon India Pharma Fund fare against peer funds in the Sectoral fund category?

Peer fund returns can vary based on the collaborative nature and specific strategies employed by fund managers of these funds listed in below table, often showcasing different risk-return profiles compared to strategy adopted by Nippon India Pharma Fund. Below table demonstrate the returns generated by some peer funds and compare tho this fund and average return generate by the Equity, Sectoral fund category these peer funds belongs to.

Fund Name 1 Month 3 Months 6 Months 1 Year 2 Years 3 Years 5 Years 10 Years
Category Best 6.02% 25.54% 21.22% 21.48% 35.98% 37.69% 38.94% 18.13%
Category Average 1.45% 6.61% 6.31% 3.13% 17.42% 20.07% 23.09% 13.07%
Nippon India Pharma Fund 3.75% 8.01% 5.60% 13.07% 26.89% 24.53% 21.59% 13.98%
Invesco India PSU Equity Fund 1.51% 10.53% 11.78% -7.83% 34.58% 37.69% 28.89% 16.08%
SBI PSU Fund 1.49% 5.87% 8.50% -6.77% 35.47% 37.37% 30.65% 12.68%
Nippon India Power & Infra Fund 2.43% 8.91% 5.36% -7.20% 29.02% 35.07% 32.34% 16.06%
ICICI Prudential Infrastructure Fund 2.44% 10.92% 10.80% 2.36% 31.15% 34.97% 37.47% 16.33%
Aditya Birla Sun Life PSU Equity Fund 1.64% 5.61% 8.65% -9.41% 32.18% 34.74% 31.22% -

Fund Portfolio Details

Portfolio details of a fund generally refer to a comprehensive breakdown of the investments held within a specific investment vehicle, such as a mutual fund or exchange-traded fund (ETF). Portfolio details of Nippon India Pharma Fund are shown below;

Equity 98.88%

Debt 0.00%

Others 1.12%

Top Equity Holdings

Name of the EquityHolding Percentage
SUN PHARMACEUTICAL INDUSTRIES LTD. 13.68%
DIVI'S LABORATORIES LTD. 9.32%
LUPIN LTD. 7.73%
CIPLA LTD. 5.90%
APOLLO HOSPITALS ENTERPRISE LTD. 5.14%
Others 58.23%
Click here to know More

Allocation by Sector

Name of the SectorHolding Percentage
Healthcare 95.49%
Consumer Services 3.39%
N/A 1.12%
Chemicals 0.88%
Others -0.88%
Click here to know More

Portfolio Holdings shown is as of 28 Feb 2025

Riskometer

Investors understand that their principal
will be at Very High risk